UBE2Q2P2

Across TCGA pan-cancer cohorts, UBE2Q2P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated UBE2Q2P2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher UBE2Q2P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2Q2P2 expression acts as an unfavorable survival marker, although some lineages such as STAD and READ show a favorable association.

KICH, THCA, and STAD are the cancer types where UBE2Q2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	II,III,IV	0.539	1.000	.002	74	view →
THCA	OS	Median	II,III,IV	0.778	0.938	.003	41	view →
STAD	OS	Median	III,IV	0.773	0.285	<.001	35	view →
READ	OS	Quartile	II,III,IV	0.968	0.313	.002	24	view →
SKCM	DFS	Quartile	All	0.773	0.547	<.001	21	view →
LIHC	DFS	Quartile	All	0.424	0.613	.001	20	view →
BLCA	DFS	Median	All	0.152	0.497	.002	14	view →
DLBC	DFS	Median	All	0.615	0.918	.007	14	view →
CESC	DFS	Quartile	III,IV	0.605	0.891	.018	10	view →
UCEC	OS	Median	III,IV	0.695	0.475	.007	10	view →
CHOL	DFS	Tertile	III,IV	0.172	0.779	.024	9	view →
KIRC	DFS	Tertile	III,IV	0.539	0.744	.008	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

UBE2Q2P2–KICH (DFS)

Open the KICH breakdown →